Year To Quarter End Statement Of Income

Noile-Immune Biotech Inc. - Filing #7338555

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Year to quarter end statement of income
Statement of income
Operating profit (loss)
-339,285,000 JPY
-269,554,000 JPY
Non-operating income
Interest income
28,000 JPY
22,000 JPY
Non-operating income
28,000 JPY
816,000 JPY
Non-operating expenses
Non-operating expenses
310,000 JPY
225,049,000 JPY
Ordinary profit (loss)
-339,567,000 JPY
-493,787,000 JPY
Profit (loss) before income taxes
-339,567,000 JPY
-493,787,000 JPY
Income taxes - current
609,000 JPY
608,000 JPY
Income taxes
609,000 JPY
608,000 JPY
Profit (loss)
-340,177,000 JPY
-494,395,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.